Excess Base Comparison Between Pregnant Subjects With Severe Preeclampsia vs. Normotensive Pregnant Women

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorSaint Thomas Hospital, Panama

About this trial

The study's primary goal is to compare the base excess (BE) values-an indicator of metabolic changes-in two groups of patients at Santo Tomás Hospital: those with severe preeclampsia and healthy, pregnant individuals. Researchers will measure these values using an arterial blood gas test before delivery or surgery.

This is a prospective cohort study. The researchers will analyze various blood gas parameters, including pH, lactate, and BE, and then correlate the BE values with clinical variables and negative maternal outcomes.

The expected outcome is that a abnormal BE values will be linked to a greater severity of preeclampsia. If this association is confirmed, BE could serve as an additional marker for predicting the severity of the condition and may lay the groundwork for future research on diagnostic and therapeutic standards based on blood gas analysis.

Eligibility criteria

Qualifiers

Gestational age: 24-40 weeks

Cases: Diagnosis of severe preeclampsia

Control: Normal blood pressure

Disqualifiers

Metabolic conditions that could hinder the results (diabetic ketoacidosis, sepsis, renal failure).

Clinical conditions that could hinder the results (diarrhea, vomit)

Recent use of bicarbonate

Trial design

Treatments tested in this trial

  • Arterial Blood gases

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators